Pharmasset (VRUS +4%) shares are on the move after favorable analyst notes: Piper Jaffray initiates coverage at Overweight, and Brean Murray raises its price target to $105 from $87. On top of that, Briefing.com reports hearing that a firm has issued positive comments regarding the company's potential valuation in an M&A scenario.
Pharmasset (VRUS +4%) shares are on the move after favorable analyst notes: Piper Jaffray...
From other sites
Video at CNBC.com (Thu, 12:00PM)
Video at CNBC.com (Jul 15, 2016)
Video at CNBC.com (Jul 12, 2016)
Video at CNBC.com (Jun 30, 2016)
Video at CNBC.com (Jun 29, 2016)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs